Non-Stimulant Strattera More Widely Available for Attention-Deficit/Hyperactivity Disorder Patients in Europe

home   >   MSN news

Strattera is approved for the treatment of ADHD in children and adolescents. Adolescents who have shown a clear benefit may also continue treatment into adulthood. ... new treatment choice Eli Lilly and Company's Strattera(R), the only approved non-stimulant medication ...

- link to Non-Stimulant Strattera More Widely Available for Attention-Deficit/Hyperactivity Disorder Patients in Europe -
Last update: 06/01/2005

Recommended Reading

    The Choices We Made: Twenty-Five Women and Men Speak Out About Abortion
    Most flu vaccine takers still go to doctor's office: despite accessibility of vaccine through clinics, stores, and workplaces, patients are still goin ... es) : An article from: Internal Medicine News
    Influenza deaths in children now notifiable.(News) : An article from: Family Practice News
    Vaccination coverage among callers to a state influenza hotline--Connecticut, 2004-05 influenza season.(Brief Report) : An article from: Morbidity and Mortality Weekly Report
    Liberty and Sexuality: The Right to Privacy and the Making of Roe V. Wade
    Sacred Work: Planned Parenthood And Its Clergy Alliances
    The Ethics of Abortion : Pro-Life Vs. Pro-Choice (Contemporary Issues)
    Colds, Flu, and Other Common Ailments: Basic Consumer Health Information About Common Ailments and Injuries, Including Colds and More (Health Reference Series)